Pre 2016

66. Cuffe, S., A.K. Azad, X. Qiu, Y. Brhane, Q. Kuang, S. Marsh, S. Savas, Z. Chen, D. Cheng, N.B. Leighl, G. Goss, S.A. Laurie, L. Seymour, P.A. Bradbury, F.A. Shepherd, M.S. Tsao, B.E. Chen, W. Xu, and G. Liu, ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. Cancer Epidemiol, 2016. 41: p. 50-6.2016Cuffe S, Azad AK, Qiu X, Brhane Y, Savas S, Bradbury PA

67. Stewart, E.L., S.Z. Tan, G. Liu, and M.S. Tsao, Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review. Transl Lung Cancer Res, 2015. 4(1): p. 67-81.2015Stewart EL

68. Stewart, E.L., C. Mascaux, N.A. Pham, S. Sakashita, J. Sykes, L. Kim, N. Yanagawa, G. Allo, K. Ishizawa, D. Wang, C.Q. Zhu, M. Li, C. Ng, N. Liu, M. Pintilie, P. Martin, T. John, I. Jurisica, N.B. Leighl, B.G. Neel, T.K. Waddell, F.A. Shepherd, G. Liu, and M.S. Tsao, Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. J Clin Oncol, 2015. 33(22): p. 2472-80.2015Stewart EL, Sykes J

69. Niu, C., L. Eng, X. Qiu, X. Shen, O. Espin-Garcia, Y. Song, D. Pringle, M. Mahler, O. Halytskyy, R. Charow, C. Lam, R.M. Shani, J. Villeneuve, K. Tiessen, M.C. Brown, P. Selby, D. Howell, J.M. Jones, W. Xu, G. Liu, and S.M. Alibhai, Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer Survivors. J Oncol Pract, 2015. 11(4): p. e450-9.2015Niu C, Eng L, Qiu X, Shen X, Espin-Garcia O, Song Y, Pringle D, Mahler M, Halytskyy O, Charow R, Lam C, Shani RM, Villeneuve J, Tiessen K

70. Moradian, S. and D. Howell, Prevention and management of chemotherapy-induced nausea and vomiting. Int J Palliat Nurs, 2015. 21(5): p. 216, 218-24.2015Moradian S

71. Huang, S.H., J.N. Waldron, M. Milosevic, X. Shen, J. Ringash, J. Su, L. Tong, B. Perez-Ordonez, I. Weinreb, A.J. Bayley, J. Kim, A. Hope, B.C. Cho, M. Giuliani, A. Razak, D. Goldstein, W. Shi, F.F. Liu, W. Xu, and B. O'Sullivan, Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer, 2015. 121(4): p. 545-55.2015Shen X

72. Graham, D.M., W. Isaranuwatchai, S. Habbous, C. de Oliveira, G. Liu, L.L. Siu, and J.S. Hoch, A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer, 2015. 121(11): p. 1785-92.2015Graham D, Habbous S

73. Eng, L., X. Qiu, J. Su, D. Pringle, C. Niu, M. Mahler, R. Charow, J. Villeneuve, O. Halytskyy, C. Lam, K. Tiessen, M.C. Brown, D. Howell, M.E. Giuliani, J.M. Jones, S.M. Alibhai, D.P. Goldstein, W. Xu, P. Selby, and G. Liu, The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers. Cancer, 2015. 121(15): p. 2655-63.2015Eng L, Qiu X, Su J, Pringle D, Nui C, Mahler M, Charow R, Villeneuve J, Halytskyy O, Lam C, Tiessen K

74. Eng, L., A.K. Azad, X. Qiu, Q.Q. Kong, D. Cheng, N. Ying, A. Tse, Q. Kuang, L. Dodbiba, D.J. Renouf, S. Marsh, S. Savas, H.J. Mackay, J.J. Knox, G.E. Darling, R.K. Wong, W. Xu, G. Liu, and O.O. Faluyi, Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Carcinogenesis, 2015. 36(9): p. 956-62.2015Eng L, Azad AK, Qiu X, Dodbiba L, Renouf DJ, Savas S

75. Dodbiba, L., J. Teichman, A. Fleet, H. Thai, M.H. Starmans, R. Navab, Z. Chen, H. Girgis, L. Eng, O. Espin-Garcia, X. Shen, B. Bandarchi, J. Schwock, M.S. Tsao, H. El-Zimaity, S.D. Der, W. Xu, R.G. Bristow, G.E. Darling, P.C. Boutros, L.E. Ailles, and G. Liu, Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers. PLoS One, 2015. 10(3): p. e0121872.2015Dodbiba L, Teichman J

76. Cuffe, S., H. Hon, K. Tobros, O. Espin-Garcia, Y. Brhane, L. Harland, E. Fadhel, L. Eng, A. LaDelfa, J. Waldron, L.L. Siu, B.E. Chen, W. Xu, C. Simmons, Z. Kassam, A. Montenegro, W.R. Parulekar, and G. Liu, Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trial. Clin Trials, 2015. 12(3): p. 237-45.2015Cuffe S, Hon H, Espin-Garcia O, Brhane Y, Harland L, Fadhel E, Eng L, LaDelfa A,

77. Wong, K.M., X. Qiu, D. Cheng, A.K. Azad, S. Habbous, P. Palepu, M. Mirshams, D. Patel, Z. Chen, H. Roberts, J. Knox, S. Marquez, R. Wong, G. Darling, J. Waldron, D. Goldstein, N. Leighl, F.A. Shepherd, M. Tsao, S. Der, D. Reisman, and G. Liu, Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. Cancer Med, 2014. 3(2): p. 426-33.2014Wong KM, Qiu X, Azad AK, Habbous S

78. Shen, X., O. Espin-Garcia, X. Qiu, Y. Brhane, G. Liu, and W. Xu, Haplotype approach for association analysis on hypertension. BMC Proc, 2014. 8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo): p. S57.2014Shen X, Espin-Garcia O, Qiu X, Brhane Y

79. Qiu, X., X. Shen, O. Espin-Garcia, A.K. Azad, G. Liu, and W. Xu, Genetic association analysis using weighted false discovery rate approach on Genetic Analysis Workshop 18 data. BMC Proc, 2014. 8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo): p. S76.2014Qiu X, Shen X, Espin-Garcia O, Azad AK

80. Habbous, S., V. Pang, W. Xu, E. Amir, and G. Liu, Human papillomavirus and host genetic polymorphisms in carcinogenesis: a systematic review and meta-analysis. J Clin Virol, 2014. 61(2): p. 220-9.2014Habbous S

81. Habbous, S., L.T. Harland, A. La Delfa, E. Fadhel, W. Xu, F.F. Liu, D. Goldstein, J. Waldron, S.H. Huang, B. O'Sullivan, and G. Liu, Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status. Head Neck, 2014. 36(6): p. 802-10.2014Habbous S, Harland LT, La Dalfa A, Fadhel E

82. Espin-Garcia, O., X. Shen, X. Qiu, Y. Brhane, G. Liu, and W. Xu, Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach. BMC Proc, 2014. 8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo): p. S70.2014Espin-Garcia O, Shen X, Qiu X, Brhane Y

83. Eng, L., J. Su, X. Qiu, P.R. Palepu, H. Hon, E. Fadhel, L. Harland, A. La Delfa, S. Habbous, A. Kashigar, S. Cuffe, F.A. Shepherd, N.B. Leighl, A.F. Pierre, P. Selby, D.P. Goldstein, W. Xu, and G. Liu, Second-hand smoke as a predictor of smoking cessation among lung cancer survivors. J Clin Oncol, 2014. 32(6): p. 564-70.2014Eng L, Qiu X, Harland L, La Delfa A, Habbous S, Cuffe S

84. Cuffe, S., H. Hon, X. Qiu, K. Tobros, C.K. Wong, B. De Souza, G. McFarlane, S. Masroor, A.K. Azad, E. Hasani, N. Rozanec, N. Leighl, S. Alibhai, W. Xu, A.M. Issa, and G. Liu, Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing. Pharmacogenet Genomics, 2014. 24(7): p. 348-55.2014Cuffe S, Hon H, Qui X

85. Bergman, H., T. Walton, R. Del Bel, J.T. Seki, A. Rafii, W. Xu, G. Koren, N. Shear, M.K. Krzyzanowska, D. Howell, and G. Liu, Managing skin toxicities related to panitumumab. J Am Acad Dermatol, 2014. 71(4): p. 754-9.2014Bergman H, Del Bel R

86. Azad, A.K., X. Qiu, K. Boyd, Q. Kuang, M. Emami, N. Perera, P. Palepu, D. Patel, Z. Chen, D. Cheng, R. Feld, N.B. Leighl, F.A. Shepherd, M.S. Tsao, W. Xu, G. Liu, and S. Cuffe, A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer, 2014. 84(3): p. 289-94.2014Azad AK, Qiu X, Cuffe S

87. Wang, J.R., S.J. Gramling, D.P. Goldstein, D. Cheng, D. Chen, A.K. Azad, A. Tse, H. Hon, Z. Chen, M. Mirshams, C. Simpson, S.H. Huang, S. Marquez, B. O'Sullivan, F.F. Liu, H. Roberts, W. Xu, D.H. Brown, R.W. Gilbert, P.J. Gullane, J.C. Irish, D.N. Reisman, and G. Liu, Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis, 2013. 34(5): p. 1012-7.2013Wang JR, Azad AK, Hon H

88. Kashigar, A., S. Habbous, L. Eng, B. Irish, E. Bissada, J. Irish, D. Brown, R. Gilbert, P. Gullane, W. Xu, S.H. Huang, I. Witterick, J. Freeman, B. O'Sullivan, J. Waldron, G. Liu, and D. Goldstein, Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. Cancer, 2013. 119(15): p. 2701-9.2013Habbous S, Eng L

89. Habbous, S., K.P. Chu, X. Qiu, A. La Delfa, L.T. Harland, E. Fadhel, A. Hui, B. Perez-Ordonez, I. Weinreb, F.F. Liu, J. Waldron, B. O'Sullivan, D. Goldstein, W. Xu, S.H. Huang, and G. Liu, The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Cancer Epidemiol, 2013. 37(6): p. 820-9.2013Habbous S, Qiu X, La Delfa A, Harland LT

90. Habbous, S., K.P. Chu, L.T. Harland, A. La Delfa, E. Fadhel, B. Sun, W. Xu, A. Wong, D. Howell, J. Ringash, J. Waldron, B. O'Sullivan, D. Goldstein, S.H. Huang, and G. Liu, Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients. Oral Oncol, 2013. 49(5): p. 407-12.2013Habbous S, Harland LT, Delfa AL, Fadhel E

91. Eng, L. and G. Liu, VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update. Pharmacogenomics, 2013. 14(13): p. 1659-67.2013Eng L

92. Azad, A.K., I. Bairati, X. Qiu, H. Huang, D. Cheng, G. Liu, F. Meyer, A. Adjei, and W. Xu, Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer, 2013. 132(11): p. 2520-7.2013Azad AK, Qiu X, Cheng D

93. Renouf, D.J., S. Welch, M.J. Moore, M.K. Krzyzanowska, J. Knox, R. Feld, G. Liu, H. MacKay, J. Petronis, L. Wang, and E. Chen, A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer. Cancer Chemother Pharmacol, 2012. 69(5): p. 1339-44.2012Renouf D

94. Liu, G., D. Cheng, K. Ding, A. Le Maitre, N. Liu, D. Patel, Z. Chen, L. Seymour, F.A. Shepherd, and M.S. Tsao, Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer. J Thorac Oncol, 2012. 7(2): p. 316-22.2012Cheng D

95. Horgan, A.M., N.B. Leighl, L. Coate, G. Liu, P. Palepu, J.J. Knox, N. Perera, M. Emami, and S.M. Alibhai, Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol, 2012. 35(4): p. 322-8.2012Horgan A, Coate L

96. Habbous, S., V. Pang, L. Eng, W. Xu, G. Kurtz, F.F. Liu, H. Mackay, E. Amir, and G. Liu, p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis. Clin Cancer Res, 2012. 18(23): p. 6407-15.2012Habbous S, Eng L

97. Geraci, J., G. Liu, and I. Jurisica, Algorithms for systematic identification of small subgraphs. Methods Mol Biol, 2012. 804: p. 219-44.2012Geraci J

98. Fehringer, G., G. Liu, M. Pintilie, J. Sykes, D. Cheng, N. Liu, Z. Chen, L. Seymour, S.D. Der, F.A. Shepherd, M.S. Tsao, and R.J. Hung, Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue. Cancer Epidemiol Biomarkers Prev, 2012. 21(7): p. 1097-104.2012Fehringer G, Sykes J, Cheng D

99. Eng, L., A.K. Azad, S. Habbous, V. Pang, W. Xu, A.H. Maitland-van der Zee, S. Savas, H.J. Mackay, E. Amir, and G. Liu, Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis. Clin Cancer Res, 2012. 18(17): p. 4526-37.2012Eng L, Habbous S, Azad AK, Savas S

100. Diaz-Padilla, I., E. Amir, S. Marsh, G. Liu, and H. Mackay, Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review. Gynecol Oncol, 2012. 124(2): p. 354-65.2012Diaz-Padilla I

101. Cheung, W.Y., R. Zhai, P. Bradbury, J. Hopkins, M.H. Kulke, R.S. Heist, K. Asomaning, C. Ma, W. Xu, Z. Wang, S. Hooshmand, L. Su, D.C. Christiani, and G. Liu, Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma. Int J Cancer, 2012. 131(11): p. 2478-86.2012Cheung WY, Bradbury P, Hopkins J

102. Azad, A.K., I. Bairati, E. Samson, D. Cheng, M. Mirshams, X. Qiu, S. Savas, J. Waldron, C. Wang, D. Goldstein, W. Xu, F. Meyer, and G. Liu, Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin Cancer Res, 2012. 18(1): p. 196-206.2012Azad AK, Cheng D, Qiu X, Savas S

103. Azad, A.K., I. Bairati, E. Samson, D. Cheng, L. Cheng, M. Mirshams, S. Savas, J. Waldron, C. Wang, D. Goldstein, W. Xu, F. Meyer, and G. Liu, Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer, 2012. 118(6): p. 1554-65.2012Azad AK, Cheng D, Qiu X, Savas S

104. Ter-Minassian, M., Z. Wang, K. Asomaning, M.C. Wu, C.Y. Liu, J.K. Paulus, G. Liu, P.A. Bradbury, R. Zhai, L. Su, C.S. Frauenhoffer, S.M. Hooshmand, I. De Vivo, X. Lin, D.C. Christiani, and M.H. Kulke, Genetic associations with sporadic neuroendocrine tumor risk. Carcinogenesis, 2011. 32(8): p. 1216-22.2011Bradbury PA

105. Sykes, J., L. Cheng, W. Xu, M.S. Tsao, G. Liu, and M. Pintilie, Addition of multiple rare SNPs to known common variants improves the association between disease and gene in the Genetic Analysis Workshop 17 data. BMC Proc, 2011. 5 Suppl 9: p. S97.2011Sykes J

106. Liu, G., S. Gramling, D. Munoz, D. Cheng, A.K. Azad, M. Mirshams, Z. Chen, W. Xu, H. Roberts, F.A. Shepherd, M.S. Tsao, and D. Reisman, Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. Oncogene, 2011. 30(29): p. 3295-304.2011Cheng D, Azad AK, Chen Z

107. Horgan, A.M., B. Yang, A.K. Azad, E. Amir, T. John, D.W. Cescon, P. Wheatley-Price, R.J. Hung, F.A. Shepherd, and G. Liu, Pharmacogenetic and germline prognostic markers of lung cancer. J Thorac Oncol, 2011. 6(2): p. 296-304.2011Horgan AM, Azad AK, Cescon DW, Wheatley-Price P

108. Horgan, A.M., J.J. Knox, G. Liu, C. Sahi, P.A. Bradbury, and N.B. Leighl, Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost-consequence analysis. Curr Oncol, 2011. 18(2): p. e64-70.2011Horgan AM

109. Coate, L.E., C. Massey, A. Hope, A. Sacher, K. Barrett, A. Pierre, N. Leighl, A. Brade, M. de Perrot, T. Waddell, G. Liu, R. Feld, R. Burkes, B.C. Cho, G. Darling, A. Sun, S. Keshavjee, A. Bezjak, and F.A. Shepherd, Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer. J Thorac Oncol, 2011. 6(3): p. 537-44.2011Coate LE

110. Cheng, L., P. Hu, J. Sykes, M. Pintilie, G. Liu, and W. Xu, A pathway-based association analysis model using common and rare variants. BMC Proc, 2011. 5 Suppl 9: p. S85.2011Sykes J

111. Wheatley-Price, P., B. Yang, D. Patsios, D. Patel, C. Ma, W. Xu, N. Leighl, R. Feld, B.C. Cho, B. O'Sullivan, H. Roberts, M.S. Tsao, M. Tammemagi, M. Anraku, Z. Chen, M. de Perrot, and G. Liu, Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma. J Clin Oncol, 2010. 28(20): p. 3316-22.2010Wheatley-Price P

112. Wang, Q., A.H. Wang, H.S. Tan, N.N. Feng, Y.J. Ye, X.Q. Feng, G. Liu, Y.X. Zheng, and Z.L. Xia, Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1,3-butadiene. Carcinogenesis, 2010. 31(5): p. 858-63.2010Wang Q

113. Liu, G., D.W. Cescon, R. Zhai, W. Zhou, M.H. Kulke, C. Ma, W. Xu, L. Su, K. Asomaning, R.S. Heist, J.C. Wain, T.J. Lynch, and D.C. Christiani, p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus, 2010. 23(1): p. 36-9.2010Cescon DW

114. Coate, L., S. Cuffe, A. Horgan, R.J. Hung, D. Christiani, and G. Liu, Germline genetic variation, cancer outcome, and pharmacogenetics. J Clin Oncol, 2010. 28(26): p. 4029-37.2010Coate L, Cuffe S, Horgan A

115. Chan, K., G. Liu, L. Miller, C. Ma, W. Xu, C.M. Schlachta, and G. Darling, Lack of correlation between a self-administered subjective GERD questionnaire and pathologic GERD diagnosed by 24-h esophageal pH monitoring. J Gastrointest Surg, 2010. 14(3): p. 427-36.2010Chan K

116. Savas, S. and G. Liu, Genetic variations as cancer prognostic markers: review and update. Hum Mutat, 2009. 30(10): p. 1369-77.2009Savas S

117. Savas, S. and G. Liu, Studying genetic variations in cancer prognosis (and risk): a primer for clinicians. Oncologist, 2009. 14(7): p. 657-66.2009Savas S

118. Savas, S., J. Geraci, I. Jurisica, and G. Liu, A comprehensive catalogue of functional genetic variations in the EGFR pathway: protein-protein interaction analysis reveals novel genes and polymorphisms important for cancer research. Int J Cancer, 2009. 125(6): p. 1257-65.2009Savas S, Geraci J

119. Cheung, W.Y., R. Zhai, M.H. Kulke, R.S. Heist, K. Asomaning, C. Ma, Z. Wang, L. Su, M. Lanuti, K.K. Tanabe, D.C. Christiani, and G. Liu, Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk. Carcinogenesis, 2009. 30(8): p. 1363-7.2009Cheung WY

120. Cheung, W.Y. and G. Liu, Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am, 2009. 38(1): p. 75-91, viii.2009Cheung WY

121. Cescon, D.W., P.A. Bradbury, K. Asomaning, J. Hopkins, R. Zhai, W. Zhou, Z. Wang, M. Kulke, L. Su, C. Ma, W. Xu, A.L. Marshall, R.S. Heist, J.C. Wain, T.J. Lynch, D.C. Christiani, and G. Liu, p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res, 2009. 15(9): p. 3103-9.2009Cescon DW, Bradbury PA, Hopkins J

122. Bradbury, P.A., R. Zhai, C. Ma, W. Xu, J. Hopkins, M.J. Kulke, K. Asomaning, Z. Wang, L. Su, R.S. Heist, T.J. Lynch, J.C. Wain, D. Christiani, and G. Liu, Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin Cancer Res, 2009. 15(14): p. 4680-5.2009Bradbury PA

123. Bradbury, P.A., R. Zhai, J. Hopkins, M.H. Kulke, R.S. Heist, S. Singh, W. Zhou, C. Ma, W. Xu, K. Asomaning, M. Ter-Minassian, Z. Wang, L. Su, D.C. Christiani, and G. Liu, Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis, 2009. 30(5): p. 793-8.2009Bradbury PA

124. Bradbury, P.A., M.H. Kulke, R.S. Heist, W. Zhou, C. Ma, W. Xu, A.L. Marshall, R. Zhai, S.M. Hooshmand, K. Asomaning, L. Su, F.A. Shepherd, T.J. Lynch, J.C. Wain, D.C. Christiani, and G. Liu, Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes. Pharmacogenet Genomics, 2009. 19(8): p. 613-25.2009Bradbury PA

125. Wheatley-Price, P., K. Asomaning, A. Reid, R. Zhai, L. Su, W. Zhou, A. Zhu, D.P. Ryan, D.C. Christiani, and G. Liu, Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer, 2008. 112(5): p. 1037-42.2008Wheatley-Price P

126. Tse, D., R. Zhai, W. Zhou, R.S. Heist, K. Asomaning, L. Su, T.J. Lynch, J.C. Wain, D.C. Christiani, and G. Liu, Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control, 2008. 19(10): p. 1077-83.2008Tse D

127. Liu, G., P. Wheatley-Price, W. Zhou, S. Park, R.S. Heist, K. Asomaning, J.C. Wain, T.J. Lynch, L. Su, and D.C. Christiani, Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Int J Cancer, 2008. 122(4): p. 915-8.2008Wheatley-Price P

128. Liu, G., S. Gurubhagavatula, W. Zhou, Z. Wang, B.Y. Yeap, K. Asomaning, L. Su, R. Heist, T.J. Lynch, and D.C. Christiani, Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib. Pharmacogenomics J, 2008. 8(2): p. 129-38.2008??

129. Hopkins, J., D.W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, I. Bairati, and G. Liu, Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev, 2008. 17(3): p. 490-9.2008Hopkins J, Cescon DW, Tse D, Bradbury P, Wheatley-Price P

130. Früh, M., W. Zhou, R. Zhai, L. Su, R.S. Heist, J.C. Wain, N.S. Nishioka, T.J. Lynch, F.A. Shepherd, D.C. Christiani, and G. Liu, Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer, 2008. 98(4): p. 689-92.2008Fruh M

131. Bradbury, P.A., R.S. Heist, M.H. Kulke, W. Zhou, A.L. Marshall, D.P. Miller, L. Su, S. Park, J. Temel, P. Fidias, L. Sequist, T.J. Lynch, J.C. Wain, F.A. Shepherd, D.C. Christiani, and G. Liu, A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Cancer Epidemiol Biomarkers Prev, 2008. 17(1): p. 204-11.2008Bradbury PA